Quinn Opportunity Partners LLC maintained its position in Vitamin Shoppe, Inc (NYSE:VSI) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,900 shares of the specialty retailer’s stock at the close of the 2nd quarter. Quinn Opportunity Partners LLC owned 0.06% of Vitamin Shoppe worth $162,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently added to or reduced their stakes in the company. Mason Street Advisors LLC lifted its stake in Vitamin Shoppe by 7.0% in the first quarter. Mason Street Advisors LLC now owns 5,569 shares of the specialty retailer’s stock worth $112,000 after acquiring an additional 366 shares during the period. BNP Paribas Arbitrage SA lifted its stake in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock worth $108,000 after acquiring an additional 192 shares during the period. Municipal Employees Retirement System of Michigan lifted its stake in Vitamin Shoppe by 18.1% in the second quarter. Municipal Employees Retirement System of Michigan now owns 9,410 shares of the specialty retailer’s stock worth $110,000 after acquiring an additional 1,440 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in Vitamin Shoppe in the first quarter worth $208,000. Finally, Arizona State Retirement System lifted its stake in Vitamin Shoppe by 0.8% in the first quarter. Arizona State Retirement System now owns 12,360 shares of the specialty retailer’s stock worth $249,000 after acquiring an additional 100 shares during the period. 96.86% of the stock is owned by hedge funds and other institutional investors.
In related news, Director John D. Bowlin acquired 40,000 shares of the firm’s stock in a transaction that occurred on Friday, August 25th. The stock was purchased at an average cost of $5.50 per share, for a total transaction of $220,000.00. Following the purchase, the director now directly owns 56,028 shares of the company’s stock, valued at approximately $308,154. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.07% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Vitamin Shoppe, Inc (VSI) Position Held by Quinn Opportunity Partners LLC” was first published by BBNS and is the property of of BBNS. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://baseballnewssource.com/markets/quinn-opportunity-partners-llc-holds-stake-in-vitamin-shoppe-inc-vsi/1601939.html.
A number of analysts recently commented on VSI shares. Bank of America Corporation reaffirmed an “underperform” rating and issued a $5.00 price target (down previously from $5.50) on shares of Vitamin Shoppe in a research note on Wednesday, August 23rd. Zacks Investment Research lowered Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Tuesday, August 15th. ValuEngine lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Deutsche Bank AG reaffirmed a “hold” rating and issued a $7.00 price target (down previously from $14.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. Finally, Barclays PLC lowered their price objective on Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating for the company in a research report on Thursday, August 10th. Four equities research analysts have rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $14.38.
Vitamin Shoppe, Inc (VSI) opened at 5.35 on Friday. The stock’s 50 day moving average price is $6.38 and its 200 day moving average price is $12.76. The company’s market capitalization is $124.24 million. Vitamin Shoppe, Inc has a one year low of $4.95 and a one year high of $28.41.
Vitamin Shoppe (NYSE:VSI) last issued its quarterly earnings data on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.16). The company had revenue of $304.84 million for the quarter, compared to analysts’ expectations of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.55 earnings per share. Equities analysts anticipate that Vitamin Shoppe, Inc will post $0.79 EPS for the current fiscal year.
Vitamin Shoppe Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with our FREE daily email newsletter.